AVO warns of potential delays as supply chain issues continue

Advanced Oncotherapy CEO Nicolas Serandour

Advanced Oncotherapy (AVO) has warned that delivery of its next generation proton beam therapy LIGHT system with a 230MeV beam could be delayed until next year due to supply chain issues. The London listed company said the international shortage of semi-conductors and thermo-switches could swing delivery of the system into Q1 2022. Losses edged up to…

You must be a HM Subscriber to view this content.

Subscribe Now »